Emails Promoting COVID-19 Vaccination Among Healthcare Workers

NCT04728594 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9566

Last updated 2021-07-26

Study results available
· View outcomes & findings →

Summary

In this evaluation, two versions of emails will be sent to Geisinger employees who have not been vaccinated against COVID-19. A delayed-contact control group will be emailed after a delay of at least two days. The researchers hypothesize that either of the emails - which use content informed by behavioral nudge theory - will lead to more COVID-19 vaccinations than the delayed-contact control group.

Conditions

  • Vaccination Refusal
  • Communication

Interventions

BEHAVIORAL

Social Proof

Email

BEHAVIORAL

Reframing

Email

BEHAVIORAL

Scarcity Message

Email

Sponsors & Collaborators

  • Geisinger Clinic

    lead OTHER

Principal Investigators

  • Michelle M Meyer, PhD · Geisinger Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-15
Primary Completion
2021-01-17
Completion
2021-01-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04728594 on ClinicalTrials.gov